Aardvark represents OpenAI’s entry into automated security research through agentic AI. By combining GPT-5’s language ...

OpenAI has introduced Aardvark, an AI-powered security researcher tool. Built on its flagship GPT-5 model, the system is designed to help developers and security teams explore vulnerabilities in ...

New preclinical results demonstrate the potential of ARD-201 in enhanced glucose control, along with preservation of lean mass, underscoring its ...

OpenAI is launching an AI agent to help developers find and verify bugs in their code. Why it matters: Tools like this could ...

In an era where cyber threats are evolving rapidly, staying ahead requires not just innovative tools, but groundbreaking technologies that ...

In a gold-standard model of obesity, treatment with ARD-201 resulted in approximately 19% body weight reduction after 30 days of treatment. ARD-201 was also associated with attenuated weight regain ...

Live webcasts of each presentation will be accessible on the company’s website, www.aardvarktherapeutics.com, under the investors section and an archived recording will be available on the website for ...

Previously focused on language models, OpenAI now enters cybersecurity with Aardvark, described as a “major advance in AI and security research.” Acting as an automated researcher, it examines entire ...

SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate ...

Each option was granted pursuant to the Aardvark Therapeutics, Inc. 2025 Inducement Equity Incentive Plan, and was granted as an inducement material to each employee’s employment with Aardvark in ...

Compelling new ARD-201 preclinical data informs optimized Phase 2 clinical development strategy of obesity programs: Phase 2 POWER trial of oral ARD-201 to focus on weight rebound in patients ...

Live webcasts of each presentation will be accessible on the company’s website, www.aardvarktherapeutics.com, under the investors section and an archived recording will be available on the website for ...